Hormone treatment may help prevent premature menopause in cancer patientsBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h6916 (Published 23 December 2015) Cite this as: BMJ 2015;351:h6916
- Jacqui Wise
Young women with breast cancer who are given a luteinising hormone releasing hormone (LHRH) analogue, triptorelin, alongside chemotherapy are more likely to retain ovarian function, a study in JAMA shows.1
Early menopause and impaired fertility are possible consequences of cancer treatment. This can add to a patient’s distress and may also affect treatment decisions. Freezing eggs or embryos is the standard procedure for fertility preservation in patients with cancer. Administering LHRH analogues during chemotherapy to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial